Home Applications 022320 Application 022320
Type NDA
Sponsor GALDERMA LABS LP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EPIDUO ADAPALENE; BENZOYL PEROXIDE GEL;TOPICAL 0.1%;2.5% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022320-001 EPIDUO ADAPALENE; BENZOYL PEROXIDE 0.1%;2.5% GEL / TOPICAL RLD 2008-12-08
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 N022320-001 8129362 2027-07-18 U-1078 2012-04-04
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N022320-001 EPIDUO 0.1%;2.5% GEL / TOPICAL AB RLD, RS 2008-12-08 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022320-001 EPIDUO 0.1%;2.5% GEL / TOPICAL AB RLD, RS 2008-12-08 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022320-001 EPIDUO 0.1%;2.5% GEL / TOPICAL AB RLD, RS 2008-12-08 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022320-001 EPIDUO 0.1%;2.5% GEL / TOPICAL RLD 2008-12-08 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 8 · 299 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022320-001 7964202 2024-09-01 U-1078 Drug product 2011-06-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022320-001 7964202 2024-09-01 U-1078 Drug product 2011-06-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022320-001 8071644 2027-07-18 U-1078 Drug product 2011-12-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022320-001 8080537 2027-07-18 U-1078 2011-12-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022320-001 8129362 2027-07-18 U-1078 2012-04-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022320-001 7964202 2024-09-01 U-1078 Drug product 2011-06-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022320-001 7820186 2025-11-23 Drug product 2010-11-02 5bbf6a4d5a75…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 2 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0299-5908 EPIDUO adapalene and benzoyl peroxide Galderma Laboratories, L.P. NDA Current 66993-869 Adapalene and Benzoyl Peroxide adapalene and benzoyl peroxide Prasco Laboratories NDA AUTHORIZED GENERIC Current